Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease (Q33263279)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease (English)

1 reference

Europe PubMed Central

24 July 2017

0 references

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Françoise Imbert-Bismut

6

object named as

Françoise Imbert-Bismut

0 references

Brigitte Le Bail

12

object named as

Brigitte Le Bail

0 references

Thierry Poynard

object named as

Thierry Poynard

1

0 references

object named as

Mona Munteanu

5

0 references

Dominique Thabut

10

object named as

Dominique Thabut

1 reference

Europe PubMed Central

24 July 2017

2

object named as

Vlad Ratziu

1 reference

Europe PubMed Central

24 July 2017

Djamila Messous

4

object named as

Djamila Messous

1 reference

Europe PubMed Central

24 July 2017

Frédéric Charlotte

3

object named as

Frederic Charlotte

1 reference

Europe PubMed Central

24 July 2017

7

object named as

Julien Massard

1 reference

Europe PubMed Central

24 July 2017

Luninita Bonyhay

8

object named as

Luninita Bonyhay

1 reference

Europe PubMed Central

24 July 2017

9

object named as

Mohamed Tahiri

1 reference

Europe PubMed Central

24 July 2017

Jean François Cadranel

11

object named as

Jean François Cadranel

1 reference

Europe PubMed Central

24 July 2017

Victor de Lédinghen

13

object named as

Victor de Ledinghen

1 reference

Europe PubMed Central

24 July 2017

author name string

Françoise Imbert-Bismut

6

1 reference

Europe PubMed Central

24 July 2017

LIDO Study Group

14

1 reference

Europe PubMed Central

24 July 2017

CYTOL study group

15

1 reference

Europe PubMed Central

24 July 2017

publication date

10 November 2006

1 reference

Europe PubMed Central

24 July 2017

BMC Gastroenterology

1 reference

Europe PubMed Central

24 July 2017

6

1 reference

Europe PubMed Central

24 July 2017

34

1 reference

Europe PubMed Central

24 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

10 November 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1471-230x-6-34

0 references

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Noninvasive measures of liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Nonalcoholic fatty liver disease: a review of current understanding and future impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

The epidemiology of fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Factors associated or related to with pathological severity of nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Motion - all patients with NASH need to have a liver biopsy: arguments against the motion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Motion - all patients with NASH need to have a liver biopsy: arguments for the motion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

alpha 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Appropriateness of liver biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Liver fibrosis in overweight patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

A 21-year experience with major hemorrhage after percutaneous liver biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

21 June 2018

Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

A novel panel of blood markers to assess the degree of liver fibrosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Silent non-alcoholic fatty liver disease-a clinical-histological study

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

31 October 2018

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-34

21 January 2018

The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657015

31 October 2018

Alpha2-Macroglobulin and Proliferative Retinopathy in Type 1 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17096854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17096854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of insulin incorporation into .alpha.2-macroglobulin: implications for the study of peptide and growth factor binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/17096854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17096854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17096854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17096854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-230X-6-34

1 reference

Europe PubMed Central

24 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33263279&oldid=2080108192"